nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—CYP11A1—Omeprazole—Barrett's esophagus	0.817	1	CbGbCtD
Mitotane—FDX1—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00462	0.167	CbGpPWpGaD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00374	0.135	CbGpPWpGaD
Mitotane—Encephalopathy—Omeprazole—Barrett's esophagus	0.00373	0.0239	CcSEcCtD
Mitotane—Encephalopathy—Esomeprazole—Barrett's esophagus	0.00373	0.0239	CcSEcCtD
Mitotane—Albuminuria—Omeprazole—Barrett's esophagus	0.0032	0.0206	CcSEcCtD
Mitotane—Albuminuria—Esomeprazole—Barrett's esophagus	0.0032	0.0206	CcSEcCtD
Mitotane—Fungal infection—Omeprazole—Barrett's esophagus	0.0031	0.0199	CcSEcCtD
Mitotane—Fungal infection—Esomeprazole—Barrett's esophagus	0.0031	0.0199	CcSEcCtD
Mitotane—Proteinuria—Omeprazole—Barrett's esophagus	0.00272	0.0175	CcSEcCtD
Mitotane—Aggression—Omeprazole—Barrett's esophagus	0.00272	0.0175	CcSEcCtD
Mitotane—Proteinuria—Esomeprazole—Barrett's esophagus	0.00272	0.0175	CcSEcCtD
Mitotane—Aggression—Esomeprazole—Barrett's esophagus	0.00272	0.0175	CcSEcCtD
Mitotane—Protein urine present—Esomeprazole—Barrett's esophagus	0.00268	0.0172	CcSEcCtD
Mitotane—Protein urine present—Omeprazole—Barrett's esophagus	0.00268	0.0172	CcSEcCtD
Mitotane—Hepatic enzyme increased—Esomeprazole—Barrett's esophagus	0.00253	0.0162	CcSEcCtD
Mitotane—Hepatic enzyme increased—Omeprazole—Barrett's esophagus	0.00253	0.0162	CcSEcCtD
Mitotane—Hepatocellular injury—Omeprazole—Barrett's esophagus	0.00239	0.0154	CcSEcCtD
Mitotane—Hepatocellular injury—Esomeprazole—Barrett's esophagus	0.00239	0.0154	CcSEcCtD
Mitotane—Neoplasm—Omeprazole—Barrett's esophagus	0.00216	0.0139	CcSEcCtD
Mitotane—Neoplasm—Esomeprazole—Barrett's esophagus	0.00216	0.0139	CcSEcCtD
Mitotane—Gynaecomastia—Omeprazole—Barrett's esophagus	0.00214	0.0137	CcSEcCtD
Mitotane—Gynaecomastia—Esomeprazole—Barrett's esophagus	0.00214	0.0137	CcSEcCtD
Mitotane—FDX1—Biological oxidations—CYP26A1—Barrett's esophagus	0.00199	0.0717	CbGpPWpGaD
Mitotane—Injury—Esomeprazole—Barrett's esophagus	0.00189	0.0121	CcSEcCtD
Mitotane—Injury—Omeprazole—Barrett's esophagus	0.00189	0.0121	CcSEcCtD
Mitotane—Osteoarthritis—Esomeprazole—Barrett's esophagus	0.00174	0.0112	CcSEcCtD
Mitotane—Diplopia—Omeprazole—Barrett's esophagus	0.00174	0.0112	CcSEcCtD
Mitotane—Diplopia—Esomeprazole—Barrett's esophagus	0.00174	0.0112	CcSEcCtD
Mitotane—Osteoarthritis—Omeprazole—Barrett's esophagus	0.00174	0.0112	CcSEcCtD
Mitotane—Irritability—Esomeprazole—Barrett's esophagus	0.00166	0.0106	CcSEcCtD
Mitotane—Irritability—Omeprazole—Barrett's esophagus	0.00166	0.0106	CcSEcCtD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00165	0.0593	CbGpPWpGaD
Mitotane—CYP11B1—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00162	0.0586	CbGpPWpGaD
Mitotane—Breast disorder—Esomeprazole—Barrett's esophagus	0.00157	0.0101	CcSEcCtD
Mitotane—Breast disorder—Omeprazole—Barrett's esophagus	0.00157	0.0101	CcSEcCtD
Mitotane—Muscular weakness—Esomeprazole—Barrett's esophagus	0.00153	0.00984	CcSEcCtD
Mitotane—Muscular weakness—Omeprazole—Barrett's esophagus	0.00153	0.00984	CcSEcCtD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00141	0.0508	CbGpPWpGaD
Mitotane—Neutropenia—Esomeprazole—Barrett's esophagus	0.0014	0.00901	CcSEcCtD
Mitotane—Neutropenia—Omeprazole—Barrett's esophagus	0.0014	0.00901	CcSEcCtD
Mitotane—CYP11A1—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00139	0.0501	CbGpPWpGaD
Mitotane—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00134	0.0086	CcSEcCtD
Mitotane—Infestation—Esomeprazole—Barrett's esophagus	0.00134	0.0086	CcSEcCtD
Mitotane—Infestation NOS—Omeprazole—Barrett's esophagus	0.00134	0.0086	CcSEcCtD
Mitotane—Infestation—Omeprazole—Barrett's esophagus	0.00134	0.0086	CcSEcCtD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00133	0.0481	CbGpPWpGaD
Mitotane—Haematuria—Esomeprazole—Barrett's esophagus	0.00128	0.0082	CcSEcCtD
Mitotane—Haematuria—Omeprazole—Barrett's esophagus	0.00128	0.0082	CcSEcCtD
Mitotane—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00127	0.00813	CcSEcCtD
Mitotane—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00127	0.00813	CcSEcCtD
Mitotane—Hepatitis—Omeprazole—Barrett's esophagus	0.0012	0.00772	CcSEcCtD
Mitotane—Hepatitis—Esomeprazole—Barrett's esophagus	0.0012	0.00772	CcSEcCtD
Mitotane—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.00119	0.00762	CcSEcCtD
Mitotane—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.00119	0.00762	CcSEcCtD
Mitotane—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00118	0.00758	CcSEcCtD
Mitotane—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00118	0.00758	CcSEcCtD
Mitotane—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00118	0.00756	CcSEcCtD
Mitotane—Urethral disorder—Omeprazole—Barrett's esophagus	0.00118	0.00756	CcSEcCtD
Mitotane—Visual impairment—Omeprazole—Barrett's esophagus	0.00116	0.00744	CcSEcCtD
Mitotane—Visual impairment—Esomeprazole—Barrett's esophagus	0.00116	0.00744	CcSEcCtD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00114	0.0412	CbGpPWpGaD
Mitotane—Eye disorder—Omeprazole—Barrett's esophagus	0.00112	0.00721	CcSEcCtD
Mitotane—Eye disorder—Esomeprazole—Barrett's esophagus	0.00112	0.00721	CcSEcCtD
Mitotane—Flushing—Omeprazole—Barrett's esophagus	0.00111	0.00716	CcSEcCtD
Mitotane—Flushing—Esomeprazole—Barrett's esophagus	0.00111	0.00716	CcSEcCtD
Mitotane—Mental disorder—Omeprazole—Barrett's esophagus	0.00105	0.00676	CcSEcCtD
Mitotane—Mental disorder—Esomeprazole—Barrett's esophagus	0.00105	0.00676	CcSEcCtD
Mitotane—Malnutrition—Esomeprazole—Barrett's esophagus	0.00105	0.00672	CcSEcCtD
Mitotane—Malnutrition—Omeprazole—Barrett's esophagus	0.00105	0.00672	CcSEcCtD
Mitotane—Dysgeusia—Omeprazole—Barrett's esophagus	0.00102	0.00658	CcSEcCtD
Mitotane—Dysgeusia—Esomeprazole—Barrett's esophagus	0.00102	0.00658	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.00101	0.0363	CbGpPWpGaD
Mitotane—Vision blurred—Esomeprazole—Barrett's esophagus	0.000985	0.00633	CcSEcCtD
Mitotane—Vision blurred—Omeprazole—Barrett's esophagus	0.000985	0.00633	CcSEcCtD
Mitotane—Tremor—Omeprazole—Barrett's esophagus	0.00098	0.00629	CcSEcCtD
Mitotane—Tremor—Esomeprazole—Barrett's esophagus	0.00098	0.00629	CcSEcCtD
Mitotane—Anaemia—Esomeprazole—Barrett's esophagus	0.000966	0.00621	CcSEcCtD
Mitotane—Anaemia—Omeprazole—Barrett's esophagus	0.000966	0.00621	CcSEcCtD
Mitotane—Vertigo—Esomeprazole—Barrett's esophagus	0.000939	0.00604	CcSEcCtD
Mitotane—Vertigo—Omeprazole—Barrett's esophagus	0.000939	0.00604	CcSEcCtD
Mitotane—Hypertension—Omeprazole—Barrett's esophagus	0.000903	0.0058	CcSEcCtD
Mitotane—Hypertension—Esomeprazole—Barrett's esophagus	0.000903	0.0058	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000884	0.00568	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000884	0.00568	CcSEcCtD
Mitotane—Confusional state—Omeprazole—Barrett's esophagus	0.00086	0.00553	CcSEcCtD
Mitotane—Confusional state—Esomeprazole—Barrett's esophagus	0.00086	0.00553	CcSEcCtD
Mitotane—Infection—Esomeprazole—Barrett's esophagus	0.000848	0.00545	CcSEcCtD
Mitotane—Infection—Omeprazole—Barrett's esophagus	0.000848	0.00545	CcSEcCtD
Mitotane—Shock—Esomeprazole—Barrett's esophagus	0.00084	0.00539	CcSEcCtD
Mitotane—Shock—Omeprazole—Barrett's esophagus	0.00084	0.00539	CcSEcCtD
Mitotane—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000837	0.00538	CcSEcCtD
Mitotane—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000837	0.00538	CcSEcCtD
Mitotane—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000836	0.00537	CcSEcCtD
Mitotane—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000836	0.00537	CcSEcCtD
Mitotane—Skin disorder—Omeprazole—Barrett's esophagus	0.000829	0.00533	CcSEcCtD
Mitotane—Skin disorder—Esomeprazole—Barrett's esophagus	0.000829	0.00533	CcSEcCtD
Mitotane—Anorexia—Omeprazole—Barrett's esophagus	0.000813	0.00523	CcSEcCtD
Mitotane—Anorexia—Esomeprazole—Barrett's esophagus	0.000813	0.00523	CcSEcCtD
Mitotane—Paraesthesia—Omeprazole—Barrett's esophagus	0.000766	0.00492	CcSEcCtD
Mitotane—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000766	0.00492	CcSEcCtD
Mitotane—Somnolence—Omeprazole—Barrett's esophagus	0.000759	0.00487	CcSEcCtD
Mitotane—Somnolence—Esomeprazole—Barrett's esophagus	0.000759	0.00487	CcSEcCtD
Mitotane—Dyspepsia—Omeprazole—Barrett's esophagus	0.000751	0.00483	CcSEcCtD
Mitotane—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000751	0.00483	CcSEcCtD
Mitotane—Decreased appetite—Omeprazole—Barrett's esophagus	0.000742	0.00477	CcSEcCtD
Mitotane—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000742	0.00477	CcSEcCtD
Mitotane—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000737	0.00473	CcSEcCtD
Mitotane—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000737	0.00473	CcSEcCtD
Mitotane—Pain—Esomeprazole—Barrett's esophagus	0.00073	0.00469	CcSEcCtD
Mitotane—Pain—Omeprazole—Barrett's esophagus	0.00073	0.00469	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—CYP26A1—Barrett's esophagus	0.000709	0.0256	CbGpPWpGaD
Mitotane—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000703	0.00452	CcSEcCtD
Mitotane—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000703	0.00452	CcSEcCtD
Mitotane—CYP11B1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000699	0.0252	CbGpPWpGaD
Mitotane—Body temperature increased—Omeprazole—Barrett's esophagus	0.000675	0.00433	CcSEcCtD
Mitotane—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000675	0.00433	CcSEcCtD
Mitotane—CYP11A1—Prostaglandin Synthesis and Regulation—PTGS2—Barrett's esophagus	0.000634	0.0229	CbGpPWpGaD
Mitotane—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000629	0.00404	CcSEcCtD
Mitotane—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000629	0.00404	CcSEcCtD
Mitotane—Asthenia—Omeprazole—Barrett's esophagus	0.000612	0.00393	CcSEcCtD
Mitotane—Asthenia—Esomeprazole—Barrett's esophagus	0.000612	0.00393	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—CYP26A1—Barrett's esophagus	0.000606	0.0219	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000598	0.0216	CbGpPWpGaD
Mitotane—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000584	0.00375	CcSEcCtD
Mitotane—Diarrhoea—Omeprazole—Barrett's esophagus	0.000584	0.00375	CcSEcCtD
Mitotane—Dizziness—Omeprazole—Barrett's esophagus	0.000564	0.00363	CcSEcCtD
Mitotane—Dizziness—Esomeprazole—Barrett's esophagus	0.000564	0.00363	CcSEcCtD
Mitotane—Vomiting—Omeprazole—Barrett's esophagus	0.000543	0.00349	CcSEcCtD
Mitotane—Vomiting—Esomeprazole—Barrett's esophagus	0.000543	0.00349	CcSEcCtD
Mitotane—Rash—Esomeprazole—Barrett's esophagus	0.000538	0.00346	CcSEcCtD
Mitotane—Rash—Omeprazole—Barrett's esophagus	0.000538	0.00346	CcSEcCtD
Mitotane—Dermatitis—Esomeprazole—Barrett's esophagus	0.000538	0.00345	CcSEcCtD
Mitotane—Dermatitis—Omeprazole—Barrett's esophagus	0.000538	0.00345	CcSEcCtD
Mitotane—Headache—Omeprazole—Barrett's esophagus	0.000535	0.00343	CcSEcCtD
Mitotane—Headache—Esomeprazole—Barrett's esophagus	0.000535	0.00343	CcSEcCtD
Mitotane—Nausea—Omeprazole—Barrett's esophagus	0.000507	0.00326	CcSEcCtD
Mitotane—Nausea—Esomeprazole—Barrett's esophagus	0.000507	0.00326	CcSEcCtD
Mitotane—FDX1—Metabolism—PTGES—Barrett's esophagus	0.000449	0.0162	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000359	0.0129	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CYP26A1—Barrett's esophagus	0.00034	0.0123	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—RELA—Barrett's esophagus	0.000311	0.0112	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000307	0.0111	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—CXCL8—Barrett's esophagus	0.000293	0.0106	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—RELA—Barrett's esophagus	0.000266	0.00961	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000251	0.00906	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—CXCL8—Barrett's esophagus	0.000251	0.00905	CbGpPWpGaD
Mitotane—FDX1—Metabolism—SLC9A1—Barrett's esophagus	0.000245	0.00884	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.000198	0.00713	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PTGES—Barrett's esophagus	0.00016	0.00577	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PTGES—Barrett's esophagus	0.000137	0.00493	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP26A1—Barrett's esophagus	0.000121	0.00437	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PPARG—Barrett's esophagus	0.000112	0.00404	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP26A1—Barrett's esophagus	0.000104	0.00374	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	8.95e-05	0.00323	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PTGS2—Barrett's esophagus	8.81e-05	0.00318	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SLC9A1—Barrett's esophagus	8.74e-05	0.00315	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	7.66e-05	0.00276	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SLC9A1—Barrett's esophagus	7.47e-05	0.00269	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	7.04e-05	0.00254	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	6.03e-05	0.00217	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PPARG—Barrett's esophagus	3.99e-05	0.00144	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PPARG—Barrett's esophagus	3.41e-05	0.00123	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PTGS2—Barrett's esophagus	3.14e-05	0.00113	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PTGS2—Barrett's esophagus	2.68e-05	0.000968	CbGpPWpGaD
